Contributions from the 2018 Literature on Bioinformatics and Translational Informatics
16 August 2019 (online)
Objectives: To summarize recent research and select the best papers published in 2018 in the field of Bioinformatics and Translational Informatics (BTI) for the corresponding section of the International Medical Informatics Association (IMIA) Yearbook.
Methods: A literature review was performed for retrieving from PubMed papers indexed with keywords and free terms related to BTI. Independent review allowed the two section editors to select a list of 14 candidate best papers which were subsequently peer-reviewed. A final consensus meeting gathering the whole IMIA Yearbook editorial committee was organized to finally decide on the selection of the best papers.
Results: Among the 636 retrieved papers published in 2018 in the various subareas of BTI, the review process selected four best papers. The first paper presents a computational method to identify molecular markers for targeted treatment of acute myeloid leukemia using multi-omics data (genome-wide gene expression profiles) and in vitro sensitivity to 160 chemotherapy drugs. The second paper describes a deep neural network approach to predict the survival of patients suffering from glioma on the basis of digitalised pathology images and genomics biomarkers. The authors of the third paper adopt a pan-cancer approach to take benefit of multi-omics data for drug repurposing. The fourth paper presents a graph-based semi-supervised method to accurate phenotype classification applied to ovarian cancer.
Conclusions: Thanks to the normalization of open data and open science practices, research in BTI continues to develop and mature. Noteworthy achievements are sophisticated applications of leading edge machine-learning methods dedicated to personalized medicine.
- 1 Butte AJ. Translational bioinformatics: Coming of age. J Am Med Inform Assoc 2008; 15 (06) 709-14
- 2 Lamy JB, Séroussi B, Griffon N, Kerdelhué G, Jaulent MC, Bouaud J. Toward a formalization of the process to select IMIA Yearbook best papers. Methods Inf Med 2015; 54 (02) 135-44
- 3 Douglas GM, Hansen R, Jones CMA, Dunn KA, Comeau AM, Bielawski JP. , et al. Multi-omics differentially classify disease state and treatment outcome in pediatric Crohn’s disease. Microbiome 2018; 6 (01) 13
- 4 Krempel R, Kulkarni P, Yim A, Lang U, Habermann B, Frommolt P. Integrative analysis and machine learning on cancer genomics data using the Cancer Systems Biology Database (CancerSysDB). BMC Bioinformatics 2018; 19 (01) 156
- 5 Lee K, Kim B, Choi Y, Kim S, Shin W, Lee S. , et al. Deep learning of mutation-gene-drug relations from the literature. BMC Bioinformatics 2018; 19 (01) 21
- 6 Lee SI, Celik S, Logsdon BA, Lundberg SM, Martins TJ, Oehler VG. , et al. A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia. Nat Commun 2018; 9 (01) 42
- 7 Lin JC, Fan CT, Liao CC, Chen YS. Taiwan Biobank: making cross-database convergence possible in the Big Data era. GigaScience 2018; 7 (01) 1-4
- 8 Mobadersany P, Yousefi S, Amgad M, Gutman DA, Barnholtz-Sloan JS, Velazquez Vega JE. , et al. Predicting cancer outcomes from histology and genomics using convolutional networks. Proc Natl Acad Sci U S A 2018; 115 (13) E2970-E2979
- 9 Moscatelli M, Manconi A, Pessina M, Fellegara G, Rampoldi S, Milanesi L. , et al. An infrastructure for precision medicine through analysis of big data. BMC Bioinformatics 2018; 19 (Suppl 10): 351
- 10 Ormondroyd E, Mackley MP, Blair E, Craft J, Knight JC, Taylor JC. , et al. Not pathogenic until proven otherwise”: perspectives of UK clinical genomics professionals toward secondary findings in context of a Genomic Medicine Multidisciplinary Team and the 100,000 Genomes Project. Genet Med 2018; 20 (03) 320-8
- 11 Sengupta S, Sun SQ, Huang KL, Oh C, Bailey MH, Varghese R. , et al. Integrative omics analyses broaden treatment targets in human cancer. Genome Med 2018; 10 (01) 60
- 12 Stoekle HC, Mamzer-Bruneel MF, Frouart CH, Le Tourneau C, Laurent-Puig P, Vogt G. , et al. Molecular Tumor Boards: Ethical Issues in the New Era of Data Medicine. Sci Eng Ethics 2018; 24 (01) 307-22
- 13 Torshizi AD, Petzold LR. Graph-based semi-supervised learning with genomic data integration using condition-responsive genes applied to phenotype classification. J Am Med Inform Assoc 2018; 25 (01) 99-108
- 14 Wolf SM, Amendola LM, Berg JS, Chung WK, Clayton EW, Green RC. , et al Navigating the research-clinical interface in genomic medicine: analysis from the CSER Consortium. Genet Med 2018; 20 (05) 545-53
- 15 Zaim SR, Li Q, Schissler AG, Lussier YA. Emergence of pathway-level composite biomarkers from converging gene set signals of heterogeneous transcriptomic responses. Pac Symp Biocomput 2018; 23: 484-95
- 16 Hristova VA, Chan DW. Cancer biomarker discovery and translation: proteomics and beyond. Expert Rev Proteomics 2019; 16 (02) 93-103
- 17 Lee E, Chuang HY, Kim JW, Ideker T, Lee D. Inferring pathway activity toward precise disease classification. PLoS Comput Biol 2008; 4 (11) e1000217
- 18 Sun SQ, Mashl RJ, Sengupta S, Scott AD, Wang W, Batra P. , et al. Database of evidence for precision oncology portal. Bioinformatics 2018; 34 (24) 4315-7